Rock West has developed the MoPill – a novel, low-cost concept for monitoring gastrointestinal motility. The solution consists of a small pill swallowed by the patient, which moves like food, with food, through the GI system. The pill location is tracked to 1 cm accuracy, every second. We monitor pill location, with no x-rays or ionizing radiation required. This simple system uniquely addresses current market need by providing a low cost, accurate, rapid GI motility assessment capability. MoPill opens untapped markets by enabling GI specialists, individuals, and home caregivers to monitor GI health and status, diagnose diseases, and treat conditions not currently possible today.
Rock West is seeking $3.1 million for prototype development, animal and human clinical trials, and 510(k) approval